Organon (OGN) Total Debt (2018 - 2026)
Organon (OGN) total debt from Dec 31, 2018 to Mar 31, 2026. The current Organon (OGN) total debt is $12B. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Total Debt
Total Debt
Organon (OGN) Total Debt CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +0.22% |
| 3 Years TTM | +61.20% |
Annual Total Debt change of Organon (OGN)
| Year | Total Debt | Change |
|---|---|---|
| 2025 | $12B | -4.07% |
| 2024 | $13B | N/A |
| 2024 | $13B | +4.13% |
| 2023 | $12B | N/A |
| 2023 | $12B | +2.37% |
| 2022 | $12B | N/A |
| 2022 | $0 | N/A |
| 2021 | $0 | N/A |
| 2021 | $0 | N/A |
| 2020 | $0 | N/A |
| 2019 | $0 | N/A |
| 2018 | $0 | N/A |
Comparison Organon (OGN) total debt with competitors
Organon (OGN) total debt is $12.09B.
| Ticker | Name | Total Debt | Upside |
|---|---|---|---|
| MIRA | Mira Pharmaceuticals Inc | $114761.00 | -100.00% |
| NSRX | Nasus Pharma Ltd | $2.24M | -99.98% |
| MDCX | MDCorp | $6.00M | -99.95% |
| MDCXW | Medicus Pharma Ltd warrant | $6.00M | -99.95% |
| AMRN | Amarin Corp | $196.35M | -98.38% |
| SCLX | Scilex Holding Company | $547.71M | -95.47% |
| BIIB | Biogen Inc | $10.83B | -10.43% |
| GRFS | Grifols SA | $12.24B | +1.25% |
| SNY | Sanofi | $54.88B | +353.82% |
| GSK | GSK Plc | $59.93B | +395.58% |
| BMY | Bristol-Myers Squibb Company | $66.37B | +448.86% |
| AZN | Astrazeneca plc | $66.63B | +450.99% |
| NVS | Novartis AG | $79.61B | +558.27% |
| PFE | Pfizer Inc | $117.21B | +869.27% |
| JNJ | Johnson & Johnson | $119.71B | +889.89% |
| NVO | Novo Nordisk | $356.16B | +2845.14% |